Thioredoxin-1 promotes survival in cells exposed to S-nitrosoglutathione: Correlation with reduction of intracellular levels of nitrosothiols and up-regulation of the ERK1/2 MAP Kinases


Autoria(s): ARAI, Roberto J.; OGATA, Fernando T.; BATISTA, Wagner L.; MASUTANI, Hiroshi; YODOI, Junji; DEBBAS, Victor; AUGUSTO, Ohara; STERN, Arnold; MONTEIRO, Hugo P.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2008

Resumo

Accumulating evidence indicates that post-translational protein modifications by nitric oxide and its derived species are critical effectors of redox signaling in cells. These protein modifications are most likely controlled by intracellular reductants. Among them, the importance of the 12 kDa dithiol protein thioredoxin-1 (TRX-1) has been increasingly recognized. However, the effects of TRX-1 in cells exposed to exogenous nitrosothiols remain little understood. We investigated the levels of intracellular nitrosothiols and survival signaling in HeLa cells over-expressing TRX-1 and exposed to S-nitrosoglutahione (GSNO). A role for TRX-1 expression on GSNO catabolism and cell viability was demonstrated by the concentration-dependent effects of GSNO on decreasing TRX-1 expression, activation of capase-3, and increasing cell death. The over-expressaion of TRX-1 in HeLa cells partially attenuated caspase-3 activation and enhanced cell viability upon GSNO treatment. This was correlated with reduction of intracellular levels of nitrosothiols and increasing levels of nitrite and nitrotyrosine. The involvement of ERK, p38 and JNK pathways were investigated in parental cells treated with GSNO. Activation of ERK1/2 MAP kinases was shown to be critical for survival signaling. lit cells over-expressing TRX-1, basal phosphorylation levels of ERK1/2 MAP kinases were higher and further increased after GSNO treatment. These results indicate that the enhanced cell viability promoted by TRX-1 correlates with its capacity to regulate the levels of intracellular nitiosothiols and to up-regulate the survival signaling pathway mediated by the ERK1/2 MAP kinases.

Fundacao de Amparo a Pesquisa do Estado de S. Paulo (FAPESP)[00/12154-2]

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Fundacao de Amparo a Pesquisa do Estado de S. Paulo (FAPESP)[02/10192-0]

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Instituto do Milenio - Redoxoma (INCT)[420011/2005]

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Identificador

TOXICOLOGY AND APPLIED PHARMACOLOGY, v.233, n.2, p.227-237, 2008

0041-008X

http://producao.usp.br/handle/BDPI/30870

10.1016/j.taap.2008.07.023

http://dx.doi.org/10.1016/j.taap.2008.07.023

Idioma(s)

eng

Publicador

ACADEMIC PRESS INC ELSEVIER SCIENCE

Relação

Toxicology and Applied Pharmacology

Direitos

restrictedAccess

Copyright ACADEMIC PRESS INC ELSEVIER SCIENCE

Palavras-Chave #Thioredoxin #Nitrosothiol #Nitric oxide #Nitrotyrosine #p21Ras #ERK1/2 MAP kinases #PROTEIN-TYROSINE PHOSPHORYLATION #COLON-CANCER CELLS #NF-KAPPA-B #NITRIC-OXIDE #REDOX REGULATION #NITROSATIVE STRESS #ENDOTHELIAL-CELLS #INDUCED APOPTOSIS #GENE-EXPRESSION #SIGNAL-TRANSDUCTION #Pharmacology & Pharmacy #Toxicology
Tipo

article

original article

publishedVersion